Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$130.65

1.54 (1.19%)

06:48
01/22/19
01/22
06:48
01/22/19
06:48

Johnson & Johnson sees FY19 adj. EPS $8.50-$8.65, consensus $8.61

Sees FY19 revenue $80.4B-$81.2B, consensus $82.68B.

  • 22

    Jan

  • 27

    Jan

  • 18

    Feb

JNJ Johnson & Johnson
$130.65

1.54 (1.19%)

01/14/19
WELS
01/14/19
NO CHANGE
Target $152
WELS
Outperform
Johnson & Johnson price target lowered to $152 from $162 at Wells Fargo
Wells Fargo analyst Larry Biegelsen lowered his price target for Johnson & Johnson to $152 from $162 ahead of quarterly results. The analyst forecasts Q4 sales of $20.1B and EPS of $1.97, versus consensus of $20.2B and $1.95, respectively. For 2019, Biegelsen expects initial guidance to be conservative based on the company's track record, and J&J to continue to target earnings to grow faster than sales. The analyst sees 5%-6% operational EPS growth as "reasonable." He reiterates an Outperform rating on the shares.
01/04/19
BTIG
01/04/19
NO CHANGE
Target $17
BTIG
Buy
Veracyte price target raised to $17 from $15 at BTIG
BTIG analyst Sung Ji Nam raised his price target on Veracyte (VCYT) to $17 and kept the Buy rating on the shares after its announced long term partnership with Johnson & Johnson (JNJ) yesterday. The analyst says the collaboration aims to accelerate the development of the first nasal swab test for early lung cancer detection and involve the two companies sharing existing data and samples from clinical studies. Sung Ji Nam states that the deal should lead to acceleration of next -gen Percepta launch, adding that the nasal swab test development could quadruple the company's total addressable market value in the U.S. alone.
01/04/19
CANT
01/04/19
NO CHANGE
Target $100
CANT
Overweight
Cantor Fitzgerald analysis suggests others could bid for Celgene
Cantor Fitzgerald analyst Alethia Young reiterates an Overweight rating on Celgene (CELG) with a $100 price target after the company reached an agreement to be acquired by Bristol-Myers Squibb (BMY). Bristol "likely got a good deal, although Celgene has intellectual property and pipeline uncertainties that are key moving pieces," Young tells investors in a research note. Her estimated net present value for Celgene is $80B, assuming some cost synergies, versus the $74B equity valuation in the Bristol deal, excluding the contingent value rights. Young's analysis indicates that companies like Amgen (AMGN) and Johnson & Johnson (JNJ) "could potentially achieve greater commercial synergies." However, the analyst thinks Celgene shareholders "may be satisfied with the current deal after quite a roller-coaster over the past 18 months."
01/02/19
SBSH
01/02/19
NO CHANGE
SBSH
Citi makes four rating changes in Medical Devices, 'warning up' to J&J
Citi analyst Amit Hazan issued his 2019 preview for Medical Devices, which included four rating changes. The analyst upgraded both Zimmer Biomet (ZBH) and Baxter International (BAX) to Buy from Neutral, downgraded Medtronic (MDT) to Neutral from Buy and downgraded Abbott Laboratories (ABT) to Sell from Neutral. He also kept Buy ratings on Intuitive Surgical (ISRG) and Boston Scientific (BSX), but adds he's "relatively more cautious." Further, Hazan kept a Sell rating on Edwards Lifesciences (EW) and says he's "warming up" to Neutral-rated Johnson & Johnson (JNJ). The analyst expects "fairly stable" fundamentals for the group in 2019, with "modest slowdowns" in organic sales and earnings growth.

TODAY'S FREE FLY STORIES

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Initiation
Teva initiated  »

Teva initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

FLIC

First Long Island

$22.35

-0.52 (-2.27%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56
Hot Stocks
First Long Island selects Christopher Becker to succeed Michael Vittorio as CEO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:51
03/19/19
03/19
16:51
03/19/19
16:51
Hot Stocks
Steelcase boosts quarterly dividend 7% to 14.5c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

PRGO

Perrigo

$49.20

0.52 (1.07%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Initiation
Perrigo initiated at SunTrust »

Perrigo initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRMK

Trustmark

$34.42

-0.7 (-1.99%)

16:50
03/19/19
03/19
16:50
03/19/19
16:50
Downgrade
Trustmark rating change at Keefe Bruyette »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

WIX

Wix.com

$108.92

1.02 (0.95%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Initiation
Wix.com initiated at Guggenheim »

Wix.com initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CG

Carlyle Group

$19.00

-0.23 (-1.20%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Hot Stocks
Carlyle Group appoints Christopher Finn COO »

Carlyle Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.31

-0.23 (-0.98%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Syndicate
Invitation Homes files to sell 43M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:49
03/19/19
03/19
16:49
03/19/19
16:49
Earnings
Steelcase sees FY20 EPS $1.20-$1.35, consensus $1.32 »

Sees FY20 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

BA

Boeing

$373.87

1.77 (0.48%)

16:48
03/19/19
03/19
16:48
03/19/19
16:48
Periodicals
Boeing CEO says understands 'lives depend' on jet safety, Reuters says »

Boeing CEO Dennis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:47
03/19/19
03/19
16:47
03/19/19
16:47
Earnings
Steelcase sees Q1 EPS 16c-20c, consensus 20c »

Sees Q1 revenue $830 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

EOLS

Evolus

, AGN

Allergan

$154.13

3.41 (2.26%)

16:46
03/19/19
03/19
16:46
03/19/19
16:46
Initiation
Evolus, Allergan initiated at SunTrust »

Evolus assumed with a Buy…

EOLS

Evolus

AGN

Allergan

$154.13

3.41 (2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 18

    May

  • 28

    May

NVCR

Novocure

$50.99

-0.11 (-0.22%)

16:45
03/19/19
03/19
16:45
03/19/19
16:45
Initiation
Novocure initiated at SunTrust »

Novocure initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated at SunTrust »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated at Guggenheim »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated at SunTrust »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated at SunTrust »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro CEO Rami Elghandour steps down, D. Keith Grossman to succeed »

Nevro announced that D.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

ENDP

Endo

$8.78

0.19 (2.21%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Endo initiated at SunTrust »

Endo initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Hot Stocks
Ramaco Resources sees FY19 production of 2.0M tons of met coal »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

COST

Costco

$237.05

0.43 (0.18%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Costco initiated at Nomura Instinet »

Costco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.